A bench, headed by Chief Justice J S Khehar, passed the order, saying all new patients should be administered daily dosage regimen of tuberculosis (TB) medicines after the expiry of a period of nine months.
The current dosage of thrice a week shall not remain in practice in any condition and as far as possible, the new drug regime be implemented, the bench, also comprising Justices N V Ramana and D Y Chandrachud, said.
The apex court bench, while passing the directions, disposed of a PIL filed by doctor and TB specialist Raman Kakkar, seeking change in the protocol for treatment of TB in the country.
Earlier this month, the apex court had asked the Centre to implement the new tuberculosis protocol saying if the drug combination is the same, then why can it not be given on a daily basis instead of thrice a week.
Terming the decision taken by the concerned department as "unscientific" and "improper", Kakkar had said the present TB protocol stipulated only an inadequate medicine regime to cut costs, adding that it promoted relapses and generated a lethal drug-resistant strain in the body of the patient.
He has claimed that over 10 per cent of TB patients suffered relapse compared with the global average of three per cent, noting that the relapsed cases were harder to treat than first-time infections.
It said more than 20 lakh TB cases are reported at government hospitals each year in the country, including between 3,500 and 4,000 in Faridabad each year.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
